Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen + N-acetylcysteine vs ibuprofen vs N-acetylcysteine in upper respiratory tract infections
2019-000242-35Phase 3Terminated
- Sponsor
- E-Pharma Trento
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in upper respiratory infection (URI) comparing Ibuprofen + N-acetylcysteine fixed-dose combination, Ibuprofen monotherapy and N-acetylcysteine monotherapy (3 arms). Primary endpoint: Time to resolution of URTI symptoms. Started Feb 2019; status: terminated.
02
Drugs
ibuprofenacetylcysteine
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on 2019-000242-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000242-35.